Business Wire

ZTI Biosciences Engages EF Hutton as Strategic and Financial Advisor

DAEJEON, South Korea--(BUSINESS WIRE)--ZTI Biosciences Co., Ltd. (“ZTI Biosciences” or “ZTI”), a radiopharmaceutical developer for cancer therapy based on nanomaterial technology, today announced that ...
Healio

Trial to evaluate safety, efficacy of ZTI-01 against cUTI

Please provide your email address to receive an email when new articles are posted on . Zavante Therapeutics has announced the initiation of a clinical trial assessing the safety and efficacy of ...
Monthly Prescribing Reference

Fosfomycin Inj Well-Tolerated in Complicated UTI, Acute Pyelonephritis

Participants included 464 hospitalized adults with cUTI or AP diagnosis, randomly assigned to be administered either ZTI-01 or piperacillin/tazobactam for a fixed 7 ...
Yahoo Finance

Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) enter into Joint Venture Agreement to focus on the development of ketamine using ZTI’s Z-pod™ technology for the ...

Englewood Cliffs, NJ, April 28, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today ...
Nature

ZTI Biosciences, Inc.

No articles found. ZTI Biosciences, Inc. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.